WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Web Hosting Web Host Industry Saturday, May 10, 2025 
Add Press Release News | News Feeds Feeds | Email This News Email


February Recap: 15 Top Health Press Releases
Saturday, March 15, 2025

A roundup of the most newsworthy healthcare press releases from PR Newswire, including business strategies shaping the future of healthcare and three major health news trends.

NEW YORK, March 7, 2025 /PRNewswire/ -- With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the month's most popular releases and newsworthy trends, here's a recap of some of the past month's most read- and engaged-with stories.

The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that are available for download.

    1. BD Announces Intent to Separate Biosciences and Diagnostic Solutions
       Business to Enhance Focus, Drive Growth and Unlock Value"Our BD 2025
       strategy has transformed the company into a faster-growing, more
       profitable organization positioned at the forefront of long-term growth
       trends in health care," said Tom Polen, chairman, CEO and president of
       BD.

    2. FDA Approves MIUDELLA®, the First Hormone-Free Copper Intrauterine
       System (IUS) in the U.S. in Over 40 Years, from Sebela Women's Health
       Inc. "This innovative intrauterine device may allow for improvements in
       discontinuation rates due to pain and bleeding and in expulsion rates.
       This would be very meaningful for women looking for hormone-free
       options," said Principal Investigator David K. Turok, MD, MPH, Professor,
       Department of Obstetrics and Gynecology, University of Utah.

    3. Lilly launches additional Zepbound vial doses and offers new savings for
       self-pay patients Self-pay patients with obesity now have additional
       Zepbound vial options, including 2.5 mg, 5 mg, 7.5 mg and 10 mg doses. In
       addition to expanding the doses available, Lilly has reduced prices of
       the 2.5 mg and 5 mg vials to $349 per month and $499 per month,
       respectively.

    4. Costa Rica Continues to Strengthen Its Position as a Leading Hub for Life
       Sciences CompaniesSince 2017, Costa Rica's medical device exports have
       grown at an average annual rate of 18%, surpassing $8 billion in 2024.
       This rapid expansion has positioned the country as Latin America's
       second-largest exporter of medical devices and the fifth-largest supplier
       of these products to the United States.

    5. The Cigna Group Launches Actions to Drive Positive Change for Customers
       and Patients"The health care system in America needs to be better, and we
       have challenged ourselves to help lead and drive systemic change," said
       David M. Cordani, chairman and CEO of The Cigna Group. "We do a lot of
       good for many people, but we need to do better for everyone. We are
       committed to implementing tangible actions across our company to help
       drive better health outcomes and health care experiences."

    6. Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New
       Drug Application for the Treatment of Spinocerebellar Ataxia Troriluzole
       has a well-established safety profile and if approved, would be the first
       and only FDA-approved treatment for Spinocerebellar Ataxia (SCA), a rare,
       genetic, life-threatening neurodegenerative disease.

    7. AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement
       to Develop Novel Tumor-Activated ImmunotherapiesThe collaboration will
       combine AbbVie's oncology expertise and Xilio's proprietary
       tumor-activation technology to develop novel immunotherapies, including
       masked T-cell engagers.

    8. Solventum Announces Sale of its Purification & Filtration Business to
       Thermo Fisher Scientific Inc. for $4.1B "We are confident that Thermo
       Fisher will provide the Purification & Filtration business - which offers
       filters and membranes for use in the manufacturing of biopharmaceutical
       and medical technologies, microelectronics and food, beverage products
       and drinking water - the strategic investment and resources needed for
       sustaining growth and delivering customer solutions," said Bryan Hanson,
       Solventum CEO.

    9. FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment
       of Diabetes As a rapid-acting insulin, Merilog helps to lower mealtime
       blood sugar spikes to improve control of blood sugar in people with
       diabetes. The approval is for both a 3 milliliter (mL) single-patient-use
       prefilled pen and a 10 milliliter (mL) multiple-dose vial.

    10. Chan Zuckerberg Initiative Launches Billion Cells Project with 10x
        Genomics and Ultima Genomics to Advance AI in Biology"Biology not only
        needs more data - the field needs more data faster and in interoperable
        formats to support AI models that address specific problems, and this
        project represents a unique approach to scaling and standardizing
        scientific outputs for AI and more," said Jonah Cool, Cell Science
        Senior Science Program Officer at CZI.

    11. Medtronic earns U.S. FDA approval for the world's first Adaptive deep
        brain stimulation system for people with Parkinson's DBS is similar to a
        cardiac pacemaker, but for the brain. It uses a surgically implanted
        neurostimulator via a minimally invasive procedure to transmit
        electrical signals to specific parts of the brain affected by
        debilitating neurological disorders.

    12. Illumina unveils first-of-its-kind spatial transcriptomics technology
        Illumina has announced a new spatial technology program that will
        empower researchers to map complex tissues and understand cellular
        behavior at an unprecedented scale. "With this innovation, we are
        setting a new bar that will drive the next wave of scientific
        discoveries and unlock a deeper understanding of biology," said Steve
        Barnard, PhD, chief technology officer of Illumina.

    13. U.S. FDA Approves EMBLAVEO(TM) (aztreonam and avibactam) for the
        Treatment of Adults With Complicated Intra-Abdominal Infections With
        Limited or No Treatment Options "As bacteria evolve, industry,
        government, and clinical experts must work together to ensure that the
        infectious disease community has the tools to advance public health,"
        said Roopal Thakkar, M.D., executive vice president, research &
        development, chief scientific officer, AbbVie. "We're proud to offer
        this important novel treatment option to urgently address the
        significant threat of antimicrobial resistance."

    14. U.S. FDA Approves Expanded Label for Astellas' IZERVAY(TM) (avacincaptad
        pegol intravitreal solution) for Geographic Atrophy Since receiving a
        permanent J-code in April 2024, IZERVAY has had month-over-month growth
        in the U.S. with more than 210,000 vials distributed through the end of
        December 2024.

    15. Texas Children's Hospital and UT MD Anderson Announce Joint Venture to
        End Childhood Cancer The partnership forms the nation's largest
        complement of pediatric subspecialty care and services to children
        diagnosed with all types of cancer within a single entity, with
        operations planned to launch in early 2026.

For more news like this, check out all of?the latest health-related releases from PR Newswire.

Trending Topics

Among the health news that was distributed in February, the PR Newswire team was able to spot several larger stories that highlight the trends shaping the industry.

    --  American Heart Month: February featured extensive focus on
        cardiovascular health with diverse awareness initiatives across multiple
        sectors. Prevention took center stage as Venus Williams invested in the
        WeWard walking app, Planet Fitness promoted strength training
        accessibility, and Texas advocates rallied for cardiac emergency
        response plans in schools during Heart Month. Former Miss Ohio Lindsay
        Davis joined cardiologists to raise awareness for hypertrophic
        cardiomyopathy, while NFL Hall of Famer Jerome Bettis partnered with the
        CDC Foundation's Live to the Beat campaign to address hypertension's
        impact on Black adults.
    --  HIMSS25: The healthcare technology sector generated significant wire
        activity surrounding the 2025 HIMSS Global Health Conference in Las
        Vegas (March 3-6). AI innovation dominated announcements, with companies
        unveiling solutions ranging from Kontaktio's agentic AI for care
        orchestration to Amtelco's AI-powered virtual agent Ellie. Industry
        collaboration also emerged as a key theme, with major EHR providers
        MedAllies, Epic, Netsmart, and eClinicalWorks announcing a joint demo,
        while Microsoft partnered with Canary Speech to advance digital health
        transformation.
    --  Rare Disease Day: As Rare Disease Day approached on Feb. 28, PR Newswire
        distributed numerous announcements highlighting advocacy efforts and
        research breakthroughs. The National Organization for Rare Disorders
        (NORD) released a critical report on newborn screening programs and
        later partnered with Paramount Pictures to amplify awareness. The Rare
        Disease Diversity Coalition prepared to host its 2nd Annual RISE Awards,
        while NFL legends joined advocates from 49 states for the 14th annual
        Rare Disease Week on Capitol Hill. Additional mainstream support for the
        rare disease community came from the New York Stock Exchange with a
        special pre-market update commemorating Rare Disease Day.

Looking ahead: This March, women's health themes will likely dominate coverage surrounding International Women's Day (March 8) and throughout Women's History Month. PR Newswire also anticipates significant activity around National Nutrition Month, with releases spotlighting dietary innovations and wellness campaigns.

Do you have a health press release to distribute? Sign up with PR Newswire to share your story with the audiences who matter most.

Helping Journalists Stay Up to Date on Industry News

These are just a few of the recent press releases that consumers and the media should know about. To be notified of releases relevant to their coverage area, journalists can set up a custom newsfeed with PR Newswire for Journalists.

Once they're signed up, reporters, bloggers, and freelancers have access to the following free features:

    --  Customization: Users can create customized newsfeeds that will deliver
        relevant news right to their inbox. Newsfeed results can be targeted by
        keywords, industry, subject, geography, and more.
    --  Photos and Videos: Thousands of multimedia assets are available to
        download and include in a journalist or blogger's next story.
    --  Subject Matter Experts: Journalists will have access to ProfNet, a
        database of industry experts to connect with as sources or for quotes in
        their articles.
    --  Related Resources: Our journalist- and blogger-focused blog, Beyond
        Bylines, features regular media news roundups, writing tips, upcoming
        events, and more.

About PR Newswire

PR Newswire is the industry's leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.

For questions, contact the team at media.relations@cision.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/february-recap-15-top-health-press-releases-302395226.html

SOURCE PR Newswire



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav VIAVI Highlights Test Solutions for AI Infrastructure Development, Manufacturing and Deployment at OFC 2025 | Mar 28, 2025
Nav Oracle Helps Customers Boost Employee Engagement with Strategic Communications and Internal Events | Mar 28, 2025
Nav ThreatQuotient positioned as a Leader in the SPARK Matrix(TM): Digital Threat Intelligence Management, 2025 by QKS Group | Mar 28, 2025
Nav Orium Launches Composable Accelerator for Shopify | Mar 28, 2025
Nav Madame Rachida Dati, French Minister of Culture, has granted official recognition to thierry Ehrmann's Abode of Chaos as a 'total work of art', the global headquarters of Artprice by Artmarket. | Mar 28, 2025
Nav Datacenter Dynamics Makes History with LoneStar - Becoming the World's First Magazine to Reach the Moon | Mar 28, 2025
Nav Nosto reports 323% growth of Personalized Search after 2024 Gartner MQ inclusion | Mar 28, 2025
Nav Western Union forms strategic partnership with HCLTech to transition to an AI led platform operating model | Mar 28, 2025
Nav Wealthbox Expands to Canada with In-Country Data Hosting | Mar 28, 2025
Nav Direct Digital Holdings Launches "Practical Generative AI Use Cases & Tools for DMOs" to Help Break New Ground in Destination Marketing With AI | Mar 28, 2025
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News